Detail
| LncRNA Name | p34822 |
| Synonyms | NA |
| Region | NA Sequence |
| Ensembl | NA |
| RefSeq | NA |
| Circulating | ✔ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 M8170/3 |
| Methods | qPCR |
| Sample | hepatocellular carcinoma tissues, cell lines (HepG2, Huh7, SMMC-7721, Hep3B, LO2) |
| Expression Pattern | up-regulated |
| Function Description | we found that plasma lncRNA p34822 is dramatically up-regulated in HCC patients.we found that circulating lncRNAs are remarkably stable at room temperature, |
| Pubmed ID | 28547580 |
| Year | 2017 |
| Title | Identification of long non-coding RNA p34822 as a potential plasma biomarker for the diagnosis of hepatocellular carcinoma. |
| External Links |
| Links for p34822 | GenBank HGNC lncrnadb Noncode |
| Links for hepatocellular carcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.